Menu

Octopuses On Ecstasy Reveal Commonalities with Humans

Just as in people, the drug stimulates the animals to behave more socially.

Sep 21, 2018
Shawna Williams
THOMAS KLEINDINST

How do you study the neuroscience of a creature whose brain bears little resemblance to that of humans? One approach, detailed yesterday (September 20) in Current Biology, is to see how the animal reacts to MDMA—also known as the street drug ecstasy. Johns Hopkins University researchers Gül Dölen and Eric Edsinger report that the drug induced social behavior in California two-spot octopuses (Octopus bimaculoides), much as it does in humans, suggesting similar roles for serotonin signaling in intelligent life throughout the animal kingdom.

“I was absolutely shocked that it had this effect,” Judit Pungor, a neuroscientist at the University of Oregon who was not involved in the research, tells NPR.

Octopuses are more closely related to snails than to humans, and their brains are organized very differently—they lack a cerebral cortex, for example. “It’s a little bit like studying alien intelligence,” Dölen tells National Geographic. “It can potentially tell us a lot about the ‘rules’ for building a nervous system that supports complex cognitive behaviors, without getting bogged down in the incidental organization of brains.” 

The genome for the California two-spot octopus was sequenced a few years ago, and in this study, Dölen and Edsinger found that it contains a gene similar to SLC6A4, which in humans encodes a serotonin transporter that binds to MDMA. That docking stimulates the release of serotonin, a neurotransmitter linked, among other things, to mood and social behavior.

To explore how the octopus version of the receptor functions, the researchers borrowed seven of the animals from Woods Hole Marine Biological Laboratory and devised a behavioral test for them. After dunking them in either a saltwater bath or a solution of MDMA, they put the octopuses in an enclosure with a toy at one end and another, caged octopus at the other.

Octopuses are not social animals, and before they received the drug, “[t]hey mashed themselves against one wall, very slowly extended one arm, touched the [other animal], and went back to the other side,” Dölen tells The Atlantic. But after the MDMA bath they spent more time near the other animal, and, she tells National Geographic, "they tended to hug the cage and put their mouth parts on the cage. . . . This is very similar to how humans react to MDMA; they touch each other frequently." 

One takeaway, Dölen tells NPR, is that "serotonin has been encoding social functions for a very, very long time. At least 500 million years ago, it started doing this function."

It’s possible the behavior could be explained by something other than social impulses, the University of Lethbridge’s Jennifer Mather, who was not involved in the study, tells The Atlantic. She suggests the drug could have affected the animals’ perception of chemical cues. “There’s no proof that it is anything more than attraction.” 

“Octopuses really are the best example we have on Earth of a second intelligence,” San Francisco State University neuroscientist Robyn Crook tells the magazine. The similarities they show with humans in the new study indicate, she says, that “there are only so many ways to make an intelligent brain.” 

Correction (September 21): The original version of this article described the protein coded for by SLC6A4 as a receptor; it is in fact a transporter. The Scientist regrets the error.

February 2019

Big Storms Brewing

Can forests weather more major hurricanes?

Marketplace

Sponsored Product Updates

Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that its QXDx AutoDG ddPCR System, which uses Bio-Rad’s Droplet Digital PCR technology, and the QXDx BCR-ABL %IS Kit are the industry’s first digital PCR products to receive U.S. Food and Drug Administration (FDA) clearance. Used together, Bio-Rad’s system and kit can precisely and reproducibly monitor molecular response to treatment in patients with chronic myeloid leukemia (CML).
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today showcases new automation features of its ZE5 Cell Analyzer during the Society for Laboratory Automation and Screening 2019 International Conference and Exhibition (SLAS) in Washington, D.C., February 2–6. These capabilities enable the ZE5 to be used for high-throughput flow cytometry in biomarker discovery and phenotypic screening.
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Researchers to benefit from an innovative software-connected pipetting system, bringing improved reproducibility and traceability of experiments to life-science laboratories.
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Incorporated (NYSE: GLW) will showcase advanced 3D cell culture technologies and workflow solutions for spheroids, organoids, tissue models, and applications including ADME/toxicology at the Society for Laboratory Automation and Screening (SLAS) conference, Feb. 2-6 in Washington, D.C.